NASDAQ · Healthcare
Invest in Vicore Pharma Holding AB stock from India
Indian and foreign residents can buy Vicore Pharma Holding AB (VCRE) shares directly through Paasa.
By Paasa · Updated
Vicore Pharma Holding AB at a glance
- Price
- $9.59-$0.06 (0.62%)
- Market cap
- $2.70B
- Day range
- $9.28 – $9.65
- P/E
- -10.19
- Dividend yield
- None
- Volume
- 27.41K
- 1 month
- -15.21%
- 6 months
- -40.98%
- YTD
- -40.98%
- 1 year
- -40.98%
- 5 years
- -40.98%
Vicore Pharma Holding AB statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | SEK 3.8M | SEK 109.3M | SEK 0.0 | SEK 0.0 | SEK 0.0 |
| Gross profit | SEK 3.8M | SEK 109.3M | SEK 0.0 | SEK 0.0 | −SEK 3.6M |
| Operating income | −SEK 454.4M | −SEK 190.4M | −SEK 321.5M | −SEK 290.7M | −SEK 32.6M |
| Net income | −SEK 477.5M | −SEK 168.6M | −SEK 310.9M | −SEK 288.4M | −SEK 295.0M |
| Earnings per share | −SEK 19.90 | −SEK 12.30 | −SEK 31.80 | −SEK 38.82 | −SEK 0.47 |
| EBITDA | −SEK 477.4M | −SEK 166.6M | −SEK 307.9M | −SEK 285.2M | −SEK 32.1M |
| Total assets | SEK 1.2B | — | — | — | — |
| Total debt | SEK 0.0 | — | — | — | — |
| Cash and short-term investments | SEK 1.2B | — | — | — | — |
| Shareholders' equity | SEK 1.1B | — | — | — | — |
| Operating cash flow | −SEK 375.7M | −SEK 164.9M | −SEK 249.6M | −SEK 299.9M | −SEK 263.8M |
| Free cash flow | −SEK 375.7M | −SEK 164.9M | −SEK 249.6M | −SEK 302.9M | −SEK 263.8M |
| Capital expenditure | SEK 0.0 | SEK 0.0 | SEK 0.0 | −SEK 3.0M | SEK 0.0 |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in SEK; a dash means the provider reported nothing for that line.
How to invest in Vicore Pharma Holding AB from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit.
Step 3
Search VCRE and buy
Find Vicore Pharma Holding AB by name or by its ticker, VCRE, and place your order. Fractional shares are available and there is no minimum trade size, so you can buy by amount instead of whole shares.
Why invest in Vicore Pharma Holding AB from India
What Vicore Pharma Holding AB does
Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include VP01, VP02, VP03, and VP04. Vicore Pharma Holding AB operates in the Biotechnology industry within the Healthcare sector.
Hold a dollar asset
Vicore Pharma Holding AB shares are priced in US dollars, so a weaker rupee adds to what they're worth in rupees. The rupee depreciated over 85% against the dollar between 2010 and 2025.
Buy a fraction of a share
Buy by amount, not by share, and get the matching fraction of one Vicore Pharma Holding AB share. There is no minimum trade size.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Vicore Pharma Holding AB stock from India?
Yes. Indian residents and NRIs can buy Vicore Pharma Holding AB (VCRE) shares directly through Paasa. Vicore Pharma Holding AB is listed on NASDAQ, in the Biotechnology industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
Do I need to buy a full Vicore Pharma Holding AB share?
No. You can buy part of one Vicore Pharma Holding AB share and add to your position over time. One share is $9.59, and you can buy whole shares or any fraction; there is no minimum trade size.
How are Vicore Pharma Holding AB dividends taxed for Indian investors?
Vicore Pharma Holding AB trades on NASDAQ but is domiciled in Sweden, so any withholding on its dividends follows that country's rules rather than those of the US. Some non-US companies list in the US through American Depositary Receipts, which can carry dividend withholding at the company's home-country rate. Dividends are taxed at your slab rate in India. Paasa's dividend report shows the gross amount and any tax withheld for each payment.
What tax do I pay in India when I sell Vicore Pharma Holding AB shares?
The US does not levy capital gains tax on shares for Indian residents. In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the USD/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.